On December 2, Bradley Fluegel notified the Board of Directors of NeuroMetrix (NURO), of his decision to resign from the Board and as a member of the Board’s Audit Committee, effective as of December ...

Medical device maker NeuroMetrix has agreed to pay $3.7 million to settle federal allegations that it gave kickbacks to physicians, according to news releases from the U.S. Attorney’s Office and ...

WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial ...

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today reported that Michael MacDonald has been promoted to SVP and General Manager of Diagnostics. In this role, Mr. MacDonald will ...

Shares have lost half their value since this spring as a number of insurers have said they would restrict reimbursement for the company's nerve tests. But some investors are betting doctors who find ...

WOBURN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) announced today that it plans to issue its 2023 first quarter financial results before the opening of the market on May 3, ...

Neurometrix Inc. (NASDAQ:NURO) shares flew higher Tuesday and Wednesday on continued momentum after the company announced its Quell device received Breakthrough Designation from the FDA for treating ...